查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1508636

腦功能成像系統市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2033年

Functional Brain Imaging Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 310 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於功能性腦影像系統全球市場的綜合報告。該報告全面評估了主要市場動態，包括市場驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

關鍵見解

  • 功能性腦部影像系統市場規模（2024 年）：50.75 億美元
  • 預測市場規模（2033 年）：90.21 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：6.6%

腦功能影像系統市場 - 研究範圍：

功能性腦部影像系統在阿茲海默症、癲癇、精神分裂症、腦腫瘤等多種神經和精神疾病的診斷和治療中發揮重要作用。這些系統利用 fMRI、PET、SPECT 和 MEG 等先進影像技術來繪製大腦活動圖，為大腦功能提供有價值的見解，並幫助開發針對性治療。功能性腦部影像系統市場面向醫院、研究機構、診斷中心和學術機構，提供多種影像模式以滿足不同的臨床和研究需求。

市場驅動因素：

全球功能性腦部影像系統市場由幾個關鍵因素推動，包括神經系統疾病盛行率的增加、影像技術的進步以及對非侵入性診斷方法的需求不斷增加。人們對早期診斷和個人化治療計劃的好處的認識不斷提高將進一步支持市場擴張。高解析度成像系統和便攜式成像設備的市場開發等技術創新提高了診斷準確性和患者舒適度，推動了市場成長。此外，功能性腦部造影在認知神經科學研究和製藥行業中的日益增長的應用為市場參與者提供了利用先進成像解決方案的新機會。

市場限制因素：

儘管成長前景廣闊，但功能性腦部造影系統市場面臨設備成本高、報銷範圍有限和嚴格的監管要求等課題。特別是在醫療保健預算有限的新興國家，功能性腦影像系統的高價格和相關的營運成本是其引入的障礙。此外，成像程序的報銷限制和管理醫療成像設備的複雜監管環境進一步影響市場成長。應對這些經濟和監管課題需要利益相關者共同努力，推廣具有成本效益的解決方案並簡化監管途徑。

市場機會：

由於技術進步、研究應用的擴大和醫療保健投資的增加，功能性腦部造影系統市場提供了巨大的成長機會。將人工智慧和機器學習整合到診斷成像系統中可以增強影像分析和解釋，從而提高診斷準確性和效率。此外，人們對大腦健康的興趣日益濃厚，神經退化性疾病的盛行率不斷上升，刺激了對先進影像技術的需求。策略聯盟、研發投資以及推出用戶友好且具有成本效益的成像解決方案對於利用新的商機並保持在動態功能性腦成像市場的領先地位至關重要。

本報告涵蓋的主要問題

  • 推動功能性腦部造影系統市場全球成長的關鍵因素是什麼？
  • 哪些影像模式和應用正在推動各種醫療機構的採用？
  • 技術進步如何改變功能性腦部影像系統市場的競爭格局？
  • 誰是功能性腦部影像系統市場的主要參與者？
  • 全球功能性腦部影像系統市場的新趨勢和未來前景是什麼？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 涵括和排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品革新/開發趨勢

第4章 重要成功要素

  • 產品採用分析
  • 主要的法規
  • 償付情勢
  • 價值鏈分析
  • PESTEL分析
  • 波特分析
  • 由於主要業者的主要的推銷策略

第5章 市場背景

  • 宏觀經濟要素
  • 預測要素- 相關性及影響
  • 市場動態

第6章 COVID-19危機分析

  • COVID-19及影響分析
    • 各產品
    • 各種模式
    • 各終端用戶
    • 各國
  • 2024年的市場情勢

第7章 全球腦功能成像系統市場需求(數量(單位)分析)

  • 過去的市場數量(單位)分析，2019年～2023年
  • 現在及未來市場規模(單位)預測，2024年～2033年
    • 前一年同期比較成長趨勢分析

第8章 全球腦功能成像系統市場- 價格分析

  • 各產品的各地區價格分析
  • 價格的明細
    • 廠商層級的價格設定
    • 分銷商層級的價格設定
  • 世界平均價格分析基準
  • 價格設定的前提

第9章 全球腦功能成像系統市場需求(價值或規模，10億美元)分析

  • 市場金額(10億美元)的過去分析，2019年～2023年
  • 現在及未來市場金額(10億美元)預測，2024年～2033年
    • 前一年同期比較成長趨勢分析
    • 絕對的美元機會分析

第10章 全球腦功能成像系統市場分析:各產品

  • 簡介/主要調查結果
  • 各產品的市場規模(10億美元)和數量(單位)的過去分析，2019年～2023年
  • 各產品的現在及未來市場規模(10億美元)和數量(單位)的分析與預測，2024年～2033年
    • 功能的 MR影像(fMRI)系統
    • 功能的近紅外線光譜法(fNIRS)系統
    • 磁腦波檢驗(MEG)系統
    • 正子放出斷層攝影(PET)系統
    • 腦波檢驗(EEG)系統
  • 各產品市場魅力分析

第11章 全球腦功能成像系統市場分析:各種模式

  • 簡介/主要調查結果
  • 各種模式的市場規模(10億美元)的過去分析，2019年～2023年
  • 各種模式的現在及未來市場規模(10億美元)分析與預測，2024年～2033年
    • 獨立的設備
    • 行動裝置
  • 各種模式市場魅力分析

第12章 全球腦功能成像系統市場分析:各終端用戶

  • 簡介/主要調查結果
  • 各終端用戶的市場規模(10億美元)的過去分析，2019年～2023年
  • 各終端用戶的現在及未來市場規模(10億美元)分析與預測，2024年～2033年
    • 醫院
    • 辦公室為基礎的診所
    • 門診病人手術中心
    • 影像診斷中心
  • 各終端用戶市場魅力分析

第13章 全球腦功能成像系統市場分析:各地區

  • 簡介
  • 各地區的市場規模(10億美元)數量(單位)的過去分析
  • 各地區的現在及未來市場金額(10億美元)和數量(單位)分析與預測，2024年～2033年
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東及非洲
  • 各地區市場的魅力分析

第14章 北美的腦功能成像系統市場分析

第15章 南美的腦功能成像系統市場分析

第16章 歐洲的腦功能成像系統市場分析

第17章 東亞的腦功能成像系統市場分析

第18章 南亞的腦功能成像系統市場分析

第19章 大洋洲的腦功能成像系統市場

第20章 中東及非洲腦功能成像系統市場分析

第21章 市場結構分析

  • 各級企業市場分析
  • 主要企業的市場佔有率分析
  • 市場影響分析

第22章 競爭分析

  • 競爭儀表板
  • 競爭詳細內容
    • Koninklijke Philips NV
    • General Electric Company
    • Canon Medical Systems Corporation
    • EB Neuro SpA
    • MinFound Medical Systems Co., Ltd
    • Neurosoft
    • Medtronic Plc
    • Nihon Kohden Corporation
    • Hitachi Medical Systems
    • Elekta
    • Siemens AG

第23章 所使用的假設和縮寫

第24章 調查手法

簡介目錄
Product Code: PMRREP23050

Persistence Market Research has recently released a comprehensive report on the worldwide market for functional brain imaging systems. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Functional Brain Imaging Systems Market Size (2024E): USD 5.075 Billion
  • Projected Market Value (2033F): USD 9.021 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.6%

Functional Brain Imaging Systems Market - Report Scope:

Functional brain imaging systems play a crucial role in the diagnosis and treatment of various neurological and psychiatric conditions, including Alzheimer's disease, epilepsy, schizophrenia, and brain tumors. These systems utilize advanced imaging techniques such as fMRI, PET, SPECT, and MEG to map brain activity, providing valuable insights into brain function and aiding in the development of targeted therapies. The market for functional brain imaging systems caters to hospitals, research institutions, diagnostic centers, and academic institutions, offering a range of imaging modalities to suit diverse clinical and research needs.

Market Growth Drivers:

The global functional brain imaging systems market is propelled by several key factors, including increasing prevalence of neurological disorders, advancements in imaging technology, and growing demand for non-invasive diagnostic methods. Rising awareness about the benefits of early diagnosis and personalized treatment plans further drive market expansion. Technological innovations, such as the development of high-resolution imaging systems and portable imaging devices, enhance diagnostic accuracy and patient comfort, fostering market growth. Moreover, the expanding application of functional brain imaging in cognitive neuroscience research and the pharmaceutical industry creates new opportunities for market players to leverage advanced imaging solutions.

Market Restraints:

Despite promising growth prospects, the functional brain imaging systems market faces challenges related to high equipment costs, limited reimbursement coverage, and stringent regulatory requirements. The high cost of functional brain imaging systems and the associated operational expenses pose barriers to adoption, particularly in emerging economies with constrained healthcare budgets. Limited reimbursement for imaging procedures and the complex regulatory landscape governing medical imaging devices further impact market growth. Addressing these economic and regulatory challenges requires concerted efforts from industry stakeholders to promote cost-effective solutions and streamline regulatory pathways.

Market Opportunities:

The functional brain imaging systems market presents significant growth opportunities driven by technological advancements, expanding research applications, and increasing healthcare investments. The integration of artificial intelligence and machine learning in imaging systems enhances image analysis and interpretation, improving diagnostic accuracy and efficiency. Furthermore, the growing focus on brain health and the rising incidence of neurodegenerative diseases stimulate demand for advanced imaging technologies. Strategic collaborations, investment in research and development, and the introduction of user-friendly, cost-effective imaging solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic functional brain imaging landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the functional brain imaging systems market globally?
  • Which imaging modalities and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the functional brain imaging systems market?
  • Who are the key players contributing to the functional brain imaging systems market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global functional brain imaging systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global functional brain imaging systems market, including GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced imaging solutions, including high-resolution fMRI, PET-CT, and portable MEG systems, catering to diverse clinical and research needs. Collaborations with healthcare providers, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving brain imaging landscape.

Key Companies Profiled:

  • Koninklijke Philips N.V.
  • General Electric Company
  • Canon Medical Systems Corporation
  • EB Neuro S.p.A.
  • MinFound Medical Systems Co., Ltd
  • Neurosoft
  • Medtronic Plc
  • Nihon Kohden Corporation
  • Siemens AG
  • Hitachi Medical Systems
  • Elekta

Key Segments Covered in Functional Brain Imaging Systems Industry Research

Product:

  • Functional MR Imaging (fMRI) System
  • Functional Near Infrared Spectroscopy (fNIRS) System
  • Magnetoencephalography (MEG) System
  • Positron Emission Tomography (PET) System
  • Electroencephalography (EEG) System

Modality:

  • Stand-Alone Device
  • Portable Device

End User:

  • Hospitals
  • Office Based Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Key Regulations
  • 4.3. Reimbursement scenario
  • 4.4. Value Chain Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis
  • 4.7. Key Promotional Strategies, By Key Players

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Medical Imaging Equipment Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Incidents of Brain Disorders
    • 5.2.2. Introduction of Novel Products
    • 5.2.3. Rising Volumes of Surgical Procedure
    • 5.2.4. Adoption Rate of Functional Brain Imaging Systems
    • 5.2.5. Rising Geriatric Population
    • 5.2.6. Increasing Government Spending and Investments
    • 5.2.7. Technological Advancements
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Modality
    • 6.1.3. By End User
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Functional Brain Imaging Systems Market Demand (in Volume (Units)) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Functional Brain Imaging Systems Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Functional Brain Imaging Systems Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. Functional MR Imaging (fMRI) System
    • 10.3.2. Functional Near Infrared Spectroscopy (fNIRS) System
    • 10.3.3. Magenetoencephalography (MEG) System
    • 10.3.4. Positron Emission Tomography (PET) System
    • 10.3.5. Electroencephalography (EEG) System
  • 10.4. Market Attractiveness Analysis By Product

11. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Modality, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Modality, 2024-2033
    • 11.3.1. Stand-Alone Device
    • 11.3.2. Portable Device
  • 11.4. Market Attractiveness Analysis By Modality

12. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Office Based Clinics
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Diagnostic Imaging Centers
  • 12.4. Market Attractiveness Analysis By End User

13. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Modality
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Modality
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Functional Brain Imaging Systems Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Modality
        • 14.8.1.2.3. By End User
    • 14.8.2. Canada Functional Brain Imaging Systems Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Modality
        • 14.8.2.2.3. By End User

15. Latin America Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Modality
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Modality
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Mexico Functional Brain Imaging Systems Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Modality
        • 15.8.1.2.3. By End User
    • 15.8.2. Brazil Functional Brain Imaging Systems Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Modality
        • 15.8.2.2.3. By End User
    • 15.8.3. Argentina Functional Brain Imaging Systems Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Modality
        • 15.8.3.2.3. By End User

16. Europe Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Modality
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Modality
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Functional Brain Imaging Systems Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Modality
        • 16.8.1.2.3. By End User
    • 16.8.2. Italy Functional Brain Imaging Systems Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Modality
        • 16.8.2.2.3. By End User
    • 16.8.3. France Functional Brain Imaging Systems Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Modality
        • 16.8.3.2.3. By End User
    • 16.8.4. U.K. Functional Brain Imaging Systems Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Modality
        • 16.8.4.2.3. By End User
    • 16.8.5. Spain Functional Brain Imaging Systems Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Modality
        • 16.8.5.2.3. By End User
    • 16.8.6. BENELUX Functional Brain Imaging Systems Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Modality
        • 16.8.6.2.3. By End User
    • 16.8.7. Russia Functional Brain Imaging Systems Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Modality
        • 16.8.7.2.3. By End User

17. East Asia Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Modality
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Modality
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Functional Brain Imaging Systems Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Modality
        • 17.8.1.2.3. By End User
    • 17.8.2. Japan Functional Brain Imaging Systems Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Modality
        • 17.8.2.2.3. By End User
    • 17.8.3. South Korea Functional Brain Imaging Systems Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Modality
        • 17.8.3.2.3. By End User

18. South Asia Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Modality
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Modality
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. India Functional Brain Imaging Systems Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Modality
        • 18.8.1.2.3. By End User
    • 18.8.2. Indonesia Functional Brain Imaging Systems Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Modality
        • 18.8.2.2.3. By End User
    • 18.8.3. Malaysia Functional Brain Imaging Systems Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Modality
        • 18.8.3.2.3. By End User
    • 18.8.4. Thailand Functional Brain Imaging Systems Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Modality
        • 18.8.4.2.3. By End User

19. Oceania Functional Brain Imaging Systems Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Modality
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Modality
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Functional Brain Imaging Systems Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Modality
        • 19.8.1.2.3. By End User
    • 19.8.2. New Zealand Functional Brain Imaging Systems Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Modality
        • 19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Modality
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Modality
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Players - Intensity Mapping
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Functional Brain Imaging Systems Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Modality
        • 20.8.1.2.3. By End User
    • 20.8.2. Turkey Functional Brain Imaging Systems Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Modality
        • 20.8.2.2.3. By End User
    • 20.8.3. South Africa Functional Brain Imaging Systems Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Modality
        • 20.8.3.2.3. By End User
    • 20.8.4. North Africa Functional Brain Imaging Systems Market Analysis
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Modality
        • 20.8.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Deep Dive
    • 22.2.1. Koninklijke Philips N.V.
      • 22.2.1.1. Overview
      • 22.2.1.2. Product Portfolio
      • 22.2.1.3. Sales Footprint
      • 22.2.1.4. Key Financials
      • 22.2.1.5. SWOT Analysis
      • 22.2.1.6. Strategy Overview
        • 22.2.1.6.1. Marketing Strategy
        • 22.2.1.6.2. Product Strategy
        • 22.2.1.6.3. Channel Strategy
    • 22.2.2. General Electric Company
      • 22.2.2.1. Overview
      • 22.2.2.2. Product Portfolio
      • 22.2.2.3. Sales Footprint
      • 22.2.2.4. Key Financials
      • 22.2.2.5. SWOT Analysis
      • 22.2.2.6. Strategy Overview
        • 22.2.2.6.1. Marketing Strategy
        • 22.2.2.6.2. Product Strategy
        • 22.2.2.6.3. Channel Strategy
    • 22.2.3. Canon Medical Systems Corporation
      • 22.2.3.1. Overview
      • 22.2.3.2. Product Portfolio
      • 22.2.3.3. Sales Footprint
      • 22.2.3.4. Key Financials
      • 22.2.3.5. SWOT Analysis
      • 22.2.3.6. Strategy Overview
        • 22.2.3.6.1. Marketing Strategy
        • 22.2.3.6.2. Product Strategy
        • 22.2.3.6.3. Channel Strategy
    • 22.2.4. EB Neuro S.p.A.
      • 22.2.4.1. Overview
      • 22.2.4.2. Product Portfolio
      • 22.2.4.3. Sales Footprint
      • 22.2.4.4. Key Financials
      • 22.2.4.5. SWOT Analysis
      • 22.2.4.6. Strategy Overview
        • 22.2.4.6.1. Marketing Strategy
        • 22.2.4.6.2. Product Strategy
        • 22.2.4.6.3. Channel Strategy
    • 22.2.5. MinFound Medical Systems Co., Ltd
      • 22.2.5.1. Overview
      • 22.2.5.2. Product Portfolio
      • 22.2.5.3. Sales Footprint
      • 22.2.5.4. Key Financials
      • 22.2.5.5. SWOT Analysis
      • 22.2.5.6. Strategy Overview
        • 22.2.5.6.1. Marketing Strategy
        • 22.2.5.6.2. Product Strategy
        • 22.2.5.6.3. Channel Strategy
    • 22.2.6. Neurosoft
      • 22.2.6.1. Overview
      • 22.2.6.2. Product Portfolio
      • 22.2.6.3. Sales Footprint
      • 22.2.6.4. Key Financials
      • 22.2.6.5. SWOT Analysis
      • 22.2.6.6. Strategy Overview
        • 22.2.6.6.1. Marketing Strategy
        • 22.2.6.6.2. Product Strategy
        • 22.2.6.6.3. Channel Strategy
    • 22.2.7. Medtronic Plc
      • 22.2.7.1. Overview
      • 22.2.7.2. Product Portfolio
      • 22.2.7.3. Sales Footprint
      • 22.2.7.4. Key Financials
      • 22.2.7.5. SWOT Analysis
      • 22.2.7.6. Strategy Overview
        • 22.2.7.6.1. Marketing Strategy
        • 22.2.7.6.2. Product Strategy
        • 22.2.7.6.3. Channel Strategy
    • 22.2.8. Nihon Kohden Corporation
      • 22.2.8.1. Overview
      • 22.2.8.2. Product Portfolio
      • 22.2.8.3. Sales Footprint
      • 22.2.8.4. Key Financials
      • 22.2.8.5. SWOT Analysis
      • 22.2.8.6. Strategy Overview
        • 22.2.8.6.1. Marketing Strategy
        • 22.2.8.6.2. Product Strategy
        • 22.2.8.6.3. Channel Strategy
    • 22.2.9. Hitachi Medical Systems
      • 22.2.9.1. Overview
      • 22.2.9.2. Product Portfolio
      • 22.2.9.3. Sales Footprint
      • 22.2.9.4. Key Financials
      • 22.2.9.5. SWOT Analysis
      • 22.2.9.6. Strategy Overview
        • 22.2.9.6.1. Marketing Strategy
        • 22.2.9.6.2. Product Strategy
        • 22.2.9.6.3. Channel Strategy
    • 22.2.10. Elekta
      • 22.2.10.1. Overview
      • 22.2.10.2. Product Portfolio
      • 22.2.10.3. Sales Footprint
      • 22.2.10.4. Key Financials
      • 22.2.10.5. SWOT Analysis
      • 22.2.10.6. Strategy Overview
        • 22.2.10.6.1. Marketing Strategy
        • 22.2.10.6.2. Product Strategy
        • 22.2.10.6.3. Channel Strategy
    • 22.2.11. Siemens AG
      • 22.2.11.1. Overview
      • 22.2.11.2. Product Portfolio
      • 22.2.11.3. Sales Footprint
      • 22.2.11.4. Key Financials
      • 22.2.11.5. SWOT Analysis
      • 22.2.11.6. Strategy Overview
        • 22.2.11.6.1. Marketing Strategy
        • 22.2.11.6.2. Product Strategy
        • 22.2.11.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology